Oxford BioMedica PLC (OXB) — Capital Reinvestment Ratio
Oxford BioMedica PLC (OXB) has a Capital Reinvestment Ratio of 0.64x as of June 2025, meaning it reinvests 1% of its operating cash flow (GBX2.35 Million) in capital expenditures (GBX1.51 Million). See debt-free asset ratio of Oxford BioMedica PLC to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oxford BioMedica PLC Capital Reinvestment Ratio (2007–2021)
This chart tracks Oxford BioMedica PLC's Capital Reinvestment Ratio across 6 annual periods. Check Oxford BioMedica PLC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Oxford BioMedica PLC (2007–2021)
Year-by-year Capital Reinvestment Ratio for Oxford BioMedica PLC from 2007 to 2021. For live market cap and broader valuation context, see how much is Oxford BioMedica PLC worth.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.37x | GBX25.45 Million | GBX9.46 Million | ▼ -91.3% |
| 2020 | 4.29x | GBX3.12 Million | GBX13.36 Million | ▲ +443.6% |
| 2018 | 0.79x | GBX12.87 Million | GBX10.15 Million | ▲ +19.3% |
| 2017 | 0.66x | GBX2.98 Million | GBX1.97 Million | ▲ +431.1% |
| 2009 | 0.12x | GBX2.31 Million | GBX288.00K | ▲ +39.8% |
| 2007 | 0.09x | GBX4.73 Million | GBX421.00K | — |